A V Enterprises

Kerendia 20 mg film-coated tablets contain finerenone, a non-steroidal mineralocorticoid receptor antagonist. Indicated for adults with chronic kidney disease (stage 3 or 4 with albuminuria) associated with type 2 diabetes, it helps reduce the risk of kidney function decline and cardiovascular events.

Verquvo is a prescription medication containing 10 mg of vericiguat, a soluble guanylate cyclase (sGC) stimulator.

Kerendia 10 mg (finerenone) film-coated tablets are prescribed for adults with chronic kidney disease associated with type 2 diabetes. They help reduce the risk of kidney function decline and cardiovascular events by blocking harmful mineralocorticoid receptor activity. Taken orally, they support kidney and heart health in affected patients.

Xarelto is an oral anticoagulant containing 10 mg of rivaroxaban, a direct Factor Xa inhibitor that prevents blood clot formation. It is prescribed for various conditions, including deep vein thrombosis (DVT), pulmonary embolism (PE), and stroke prevention in non-valvular atrial fibrillation (AF).

Visanne 2 mg tablets contain dienogest, a synthetic progestin used to manage endometriosis—a condition where tissue similar to the uterine lining grows outside the uterus. By suppressing estradiol production, Visanne reduces endometrial growth and alleviates associated pelvic pain.

Estradiol Valerate and Dienogest tablets combine estrogen and progestin to prevent pregnancy and treat heavy menstrual bleeding. Taken daily in a specific sequence, they regulate hormonal balance. Suitable for contraception and menstrual management, these tablets require medical guidance due to potential side effects like blood clots and hormonal changes.